Clinical comparison and functional study of the L703P: a recurrent mutation in human SCN4A that causes sodium channel myotonia

Neuromuscul Disord. 2022 Oct;32(10):811-819. doi: 10.1016/j.nmd.2022.08.004. Epub 2022 Aug 17.

Abstract

The non-dystrophic myotonias are inherited skeletal muscle disorders characterized by skeletal muscle stiffness after voluntary contraction, without muscle atrophy. Based on their clinical features, non-dystrophic myotonias are classified into myotonia congenita, paramyotonia congenita, and sodium channel myotonia. Using whole-exome next-generation sequencing, we identified a L703P mutation (c.2108T>C, p.L703P) in SCN4A in a Chinese family diagnosed with non-dystrophic myotonias. The clinical findings of patients in this family included muscle stiffness and hypertrophy. The biophysical properties of wildtype and mutant channels were investigated using whole-cell patch clamp. L703P causes both gain-of-function and loss-of-function changes in Nav1.4 properties, including decreased current density, impaired recovery, enhanced activation and slow inactivation. Our study demonstrates that L703P is a pathogenic variant for myotonia, and provides additional electrophysiological information for understanding the pathogenic mechanism of SCN4A-associated channelopathies.

Keywords: Non-dystrophic myotonias; Patch clamp; SCN4A; Sodium channel myotonia; Voltage-gated sodium channel.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Mutation
  • Myotonia Congenita* / genetics
  • Myotonia* / diagnosis
  • Myotonia* / genetics
  • Myotonic Disorders* / genetics
  • NAV1.4 Voltage-Gated Sodium Channel / genetics

Substances

  • NAV1.4 Voltage-Gated Sodium Channel
  • SCN4A protein, human

Supplementary concepts

  • Potassium aggravated myotonia